Discussions regarding Medicaid 340B drug discount program
Reducing Out-of-Pocket Costs for Biosimilars in Medicare Part B IP/Trade TRIPS Waiver Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, PET scan coverage and reimbursement, and dementia care
Appropriations on Alzheimers screening and diagnosis
Discussions regarding H.R. 1319, the American Rescue Plan
S.1427/H.R.2869, Increasing Access to Biosimilars Act of 2021
H.R.2815, Bolstering Innovative Options to Save Immediately on Medisines (BIOSIM) Act
H.R.2855, Star Rating for Biosimilars H.R.3/S.2543, Elijah E. Cummings Lower Drug Costs Now Act, discussions regarding support to increase Part B biosimilar payments from ASP +6% to ASP +8% of the reference product
Oppose drug pricing proposals that include international procing index (IPI) or similar policies, Medicare drug negotiation, Medicare Part D redesign (including sections in H.R.3, S.2543, H.R.19. S.3129)
Education and discussions regarding pharmaceutical issues related to supply chain
MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) HCR - Health Issues PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
MICHELLE MATHY CHRISTINA HOCHUL AMY DEMSKE JONATHAN CAUSEY MICHELLE MATHY STEPHANIE A. DYSON JONATHAN CAUSEY MICHELLE MATHY JOHN RAYMOND GIBSON CHUCK SHIH CAROLINE TUCKER SUSAN KORNETSKY AMY DEMSKE STEPHANIE A. DYSON JONATHAN CAUSEY MICHELLE MATHY